Cargando…
Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing
Only half of patients with hypertension (HTN) respond to any given antihypertensive medication. Heterogeneity in pathophysiologic pathways underlying HTN is a major contributor. Personalizing antihypertensive therapy could improve blood pressure (BP) reduction. The objective of this study was to ass...
Autores principales: | Mehanna, Mai, Chen, Yiqing E., Gong, Yan, Handberg, Eileen, Roth, Brittney, De Leon, Jessica, Smith, Steven M., Harrell, Jonathan G., Cooper‐DeHoff, Rhonda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993275/ https://www.ncbi.nlm.nih.gov/pubmed/33142006 http://dx.doi.org/10.1111/cts.12922 |
Ejemplares similares
-
Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients
por: Mehanna, Mai, et al.
Publicado: (2021) -
Simple Integer Risk Score to Determine Prognosis of Patients With Hypertension and Chronic Stable Coronary Artery Disease
por: Bavry, Anthony A., et al.
Publicado: (2013) -
Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial
por: Dasa, Osama, et al.
Publicado: (2021) -
THE IMPACT OF THE COVID-19 PANDEMIC ON A MULTI-CENTER CLINICAL - ADAPTING IN REAL-TIME TO MAINTAIN TRIAL INTEGRITY
por: Dasa, Osama, et al.
Publicado: (2021) -
Medication Adherence—Still the Holy Grail
por: Cooper‐DeHoff, Rhonda M., et al.
Publicado: (2023)